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Nitric oxide (NO) effects on the cardiac mitochondrial voltage-dependent anion channel (VDAC) are
unknown. The effects of exogenous NO on VDAC puriﬁed from rat hearts were investigated in this
study. When incorporated into lipid bilayers, VDAC was inhibited directly by an NO donor, PAPA
NONOate, in a concentration-dependent biphasic manner. This was prevented by an NO scavenger,
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide. The effect paralleled that of NO in delay-
ing the opening of the mitochondrial permeability transition (PT) pore. These biphasic effects on
the cardiac VDAC and the mitochondrial PT pore reveal a tandem impact of NO on the two mito-
chondrial entities.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Nitric oxide (NO) has been shown to play a complex role in car-
dioprotection against ischemia-reperfusion injury [1]. Exogenous
NO has been shown to mediate cardioprotection in a dose-depen-
dent manner, where protection is abrogated at high levels of NO
[2]. The cardioprotection afforded by NO is partially attributed to
its direct and indirect effects on preserving mitochondrial function.
NO prevents the opening of the mitochondrial permeability transi-
tion (PT) pore, thus averting a key end-stage event that leads to
apoptotic and necrotic cell death [3,4]. However, the exact nature
of the interaction of NO with the PT pore is unknown. This is in
large part due to the lack of the molecular identity of the PT pore
complex [5]. NO also targets the complexes of the electron trans-
port chain and can activate the mitochondrial ATP-sensitive potas-
sium channel [6,7]. Thus, how these multiple actions of NO on the
mitochondria work in concert to ultimately lead to cardioprotec-
tion is yet to be elucidated.chemical Societies. Published by E
pendent anion channel; PPN,
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esiology, Medical College of
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).Other mitochondrial proteins may also be targeted by NO. The
voltage-dependent anion channel (VDAC) is the major conduit that
allows for the diffusional exchange of nucleotides and metabolites
across the outer mitochondrial membrane (OMM) [8]. Although re-
cent studies have provided evidence that excluded VDAC as a com-
ponent of the PT pore as previously thought, VDAC plays a critical
role in the maintenance of mitochondrial function, and ultimately
to preservation of cellular function [8]. Yet, its sensitivity to NO
has not been established. Speciﬁcally, its effect on the cardiac
VDAC is unknown. The main objective of this study was to deter-
mine the direct effect of exogenous NO on the cardiac VDAC. The
VDAC protein was puriﬁed from rat hearts and incorporated into
planar lipid bilayers to monitor its activity at the single channel le-
vel. In addition, the effects of NO on the opening of the cardiac
mitochondrial PT pore were also investigated and compared to
those on VDAC to determine whether NO had parallel effects on
these two mitochondrial entities.
2. Materials and methods
2.1. Puriﬁcation of cardiac VDAC
Upon approval by the Institutional Animal Care and Use Com-
mittee (IACUC), mitochondria were isolated from hearts of male
Wistar rats (250–300 g) as previously described [7]. VDAC was
puriﬁed from the isolated mitochondria following a previously
reported procedure with modiﬁcations [9]. Mitochondria werelsevier B.V. All rights reserved.
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10 mM Tris, 0.15 mM PMSF, 0.04 mM leupeptin hydrochloride, and
3% Triton X-100 with pH 7.0. Following centrifugation at 44 000g
for 30 min at 4 C, the supernatant was loaded onto a dry hydroxy-
apatite/Celite (2:1 wt/wt) column (0.1 g/mg protein) and eluted
with a buffer containing 10 mM Tris, and 3% Triton X-100 with
pH 6.8. Fractions of the VDAC-containing eluent were collected, di-
luted threefold with 10 mM Tris, pH 7.4, and loaded onto a reactive
red-agarose column which was pre-equilibrated with 10 mM Tris,
pH 7.4, and 0.4% Nonidet P-40. VDAC was eluted with the same
buffer but with the addition of 0.3 M NaCl. Following separation
by SDS–PAGE (4–20%: Bio-Rad Laboratories, Hercules, CA) the
bands were silver stained (Silver Stain Kit, Sigma–Aldrich, St. Louis,
MO). Western blot analysis for VDAC followed standard procedure
with a polyclonal VDAC antibody (EMD Chemical, Gibbstown, NJ).
2.2. Reconstitution of VDAC into planar lipid bilayers
Phospholipids were prepared by mixing phosphatidylethanol-
amine, phosphatidylserine and phosphatidylcholine (Avanti Polar
Lipids, Alabaster, AL) in a ratio of 5:4:1 (v/v), dried under nitrogen,
and resuspended in n-decane for a ﬁnal concentration of 25 mg/ml.
The cis/trans chambers contained symmetrical solutions of 10 mM
HEPES, 500 mM NaCl and 1 mM CaCl2 with pH 7.4. The cis chamber
was held at virtual ground and the trans chamber was held at the
command voltages. The VDAC protein and mediators were added
into the cis chamber. Currents were digitized at 5 kHz and low pass
ﬁltered at 1 kHz using a voltage clamp ampliﬁer (Axopatch 200B,
Molecular Devices, Sunnyvale, CA) via a digitizer (DigiData 1332,
Molecular Devices), and recorded in 2-min segments. The pClamp
software (version 9, Molecular Devices) was used for data acquisi-
tion and analysis. Additional analysis was conducted using Origin
7.0 (OriginLab, Northampton, MA). PAPA NONOate (PPN) was made
fresh in 10 mM NaOH and diluted to the desired concentrations in
the recording buffer. The levels of NO generated by the different
concentrations of PPN were determined using an NO-sensitive
electrode connected to a free radical analyzer (APOLLO 4000,World
Precision Instruments, Sarasota, FL). An NO scavenger, 2-phenyl-
4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO; EMD Biosci-
ences, San Diego, CA) was prepared in cold deionized water. The
ﬁnal concentration of PTIO in bufferwas 25 lM. Koenig’s polyanion,
a VDAC antagonist was kindly provided by Dr. Marco Colombini
(University of Maryland).
2.3. Measurement of mitochondrial PT pore opening
Opening of the PT pore was measured as described previously
[10,11]. Following approval by the IACUC, cardiomyocytes were
enzymatically isolated from the rat hearts as previously described
[12] and loaded with the ﬂuorescent indicator tetramethylrhod-
amine ethyl ester (TMRE, 100 nM; Invitrogen, Carlsbad, CA) for
25 min at room temperature. After dye loading, selected regions
of myocyte (50  50 lm) were consecutively illuminated with a
HeNe laser at 543 nm, thereby generating oxidative stress that
caused PT pore opening. The emitted ﬂuorescence was collected
at 590 nm. Cells were imaged using a confocal microscope (Eclipse
TE2000-U; Nikon, Tokyo, Japan) with a 60/1.4 oil-immersion
objective. The obtained images were analyzed with MetaMorph
6.2 software (Universal Imaging, West Chester, PA). The PT pore
opening time was determined as the time when TMRE ﬂuorescence
intensity decreased by 50% between the initial and residual values
after PT pore opening. This correlated with the mean PT pore open-
ing time of approximately 50% of mitochondria in the recorded re-
gion [10]. To test the effect NO on PT pore opening, cells were
loaded for 20 min with NO donors, either PPN or S-nitroso-N-ace-
tylpenicillamine (SNAP; Tocris Bioscience, Ellisville, MO). PPN wasprepared as described above and SNAP was prepared in dimethyl
sulfoxide and diluted to the desired concentrations. All the exper-
iments were conducted at room temperature.
2.4. Statistical analysis
Data are shown as mean ± SEM. One-way ANOVA followed by
Scheffe’s test was used to compare the data among groups.
P < 0.05 was considered signiﬁcantly different.3. Results
3.1. Puriﬁcation and identiﬁcation of VDAC
The enrichment of the VDAC protein from isolated heart mito-
chondria is depicted in Fig. 1A. The silver staining gel shows the
mitochondria and VDAC-containing fractions. Western blot analy-
sis conﬁrmed the identity of the VDAC (molecular weight of
31 kDa) in the VDAC-containing fractions. To further conﬁrm the
identity of the puriﬁed protein, VDAC was incorporated into a pla-
nar lipid bilayer. A key feature of VDAC is its voltage-dependence
whereby the greatest conductance is observed at membrane volt-
ages near 0 mV. This is demonstrated in Fig. 1B where VDAC activ-
ity was recorded using a voltage ramp protocol from 80 to
+80 mV with a 0 mV holding potential. As shown, the peak conduc-
tance of 1.8 nS occurred at voltages between 40 and +60 mV. The
normalized conductance at the various membrane potentials are
summarized in Fig. 1C depicting the voltage-dependent character-
istic of VDAC. Furthermore, the reconstituted VDAC was inhibited
by Koenig’s polyanion, its putative inhibitor (Fig. 1D). In the exam-
ple shown, the application of the polyanion resulted in a decrease
in the channel’s chord conductance from 1.7 nS to 700 pS.
3.2. Effect of NO on VDAC
The effect of NO on the reconstituted VDAC was investigated
using PPN. This compound was chosen due to its stability at room
temperature. Each electrophysiological recording was completed
within 30 min. A representative channel activity is depicted in
Fig 2A. As shown, at a concentration of 25 lM, PPN inhibited VDAC
activity and resulted in lower conductance states. The cumulative
amplitude histogram from n = 10 separate recordings revealed
multiple low conductance states in the presence of PPN. At a higher
concentration of 50 lM, the effects of PPN on VDAC appeared to be
less than those of 25 lM, as shown in Fig 2B. In particular, fewer
low conductance states were revealed. The result toward lower
conductances in the presence of PPN is also demonstrated in
Fig. 2C where VDAC activity was recorded in response to a voltage
ramp protocol from three separate recordings. In the absence of
PPN, the channel exhibited the characteristic voltage-dependence
with the high conductance open state of 1.8 nS predominant at
voltages between 60 and +60 mV. Upon the addition of 25 lM
PPN, the predominant conductance through the voltage range of
80 to +80 mV was a low conductance closed state of 0.6 nS. To
rule out time-dependent effects, a time course protocol was imple-
mented to monitor VDAC activity over a 30-min time period under
control conditions, in the absence of PPN. As shown in Fig. 3, the
cumulative amplitude histogram (n = 5) at three different time
points demonstrated the stability of the VDAC recordings. Thus,
the effects of PPN were not due to channel ‘‘run-down’’.
The summary of the effects of NO on VDAC is shown in Fig. 4A.
Due to multiple conductance states, VDAC activity was determined
as the mean current during multiple recording sets of 2-min
durations. The effects of NO on VDAC were determined after stea-
dy-state conditions were reached. The mean time to steady-state
Fig. 1. Puriﬁcation and functional identiﬁcation of VDAC. VDAC was puriﬁed from mitochondria isolated from rat heart. Panel A: VDAC bands are shown on a silver-staining
gel andWestern blot. Std = kD standards; Mito = mitochondrial sample; columns 1,2 = VDAC-containing fractions eluted from an active red-agarose column. Panel B: Channel
current recorded during a linear voltage-ramp protocol from 80 to +80 mV from a holding potential of 0 mV is shown. Panel C: Normalized conductances were obtained at
the various membrane potentials. Conductance was determined from the peak current amplitude recorded at the indicated membrane potentials (n = 6 recordings). Panel D:
Sample VDAC traces and the corresponding all-points amplitude histograms are shown in control and in the presence of 2 lM Koenig’s polyanion, a VDAC antagonist.
Recordings were obtained at a membrane potential of 10 mV. The dashed lines indicate zero current levels.
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have concentration-dependent and biphasic inhibitory effects on
VDAC. At 25 lM where the peak inhibition was observed, PPN
inhibited VDAC by approximately 40%. The inhibitory effects were
attenuated at higher concentrations. The corresponding levels of
NO generated by PPN were also determined. NO levels generated
by PPN were stable under our room temperature conditions for at
least 30 min (Fig. 4B). Based on our measurements, the biphasic
inhibitory effect occurred within the range of 120–900 nM of
NO. The PPN of 25 lM, where the peak inhibition of VDAC oc-
curred, corresponded to an NO level of approximately 350 nM.
This was within the physiological range of NO levels that have
been demonstrated to be anti-apoptotic [3].
To further conﬁrm the effect of PPN, experiments were con-
ducted to test whether an NO scavenger would prevent the inhibi-
tion on VDAC. PTIO was added simultaneously with PPN to the
recording buffer solution. In the presence of PTIO, PPN at 25 lM
was unable to inhibit VDAC activity (Fig. 4C). Consequently, this
supported the observation that the inhibitory effect of PPN on
VDAC was due to the generated NO.
3.3. Effect of NO on the cardiac mitochondrial PT pore
NO has been reported to inhibit the opening of the PT pore of
mitochondria isolated from liver in a concentration-dependent
manner [3]. Low levels of NO inhibited PT pore opening, while
higher levels accelerated its opening. Therefore, we investigatedwhether there was a similar effect of NO on the PT pore opening
in isolated cardiomyocytes and whether this paralleled the effects
of NO on VDAC observed above. Changes in mitochondrial mem-
brane potential (DWm) as a function of TMRE ﬂuorescence were
used as an indicator of PT pore opening. Two commonly used
NO donors, SNAP and PPN, were used for these experiments, and
the experimental protocol is shown in Fig. 5A. As depicted in a rep-
resentative recording in Fig. 5B, SNAP triggered a concentration-
dependent delay in the opening of the cardiac PT pore. At the low-
est concentration of 0.1 mM, SNAP triggered a delay in the PT pore
opening compared to the control condition in the absence of the
NO donor. This was not evident at the higher SNAP concentrations.
The results are summarized in Fig. 5C. Experiments with PPN
showed a similar trend, with a delay in PT pore opening at a con-
centration of 25 lM and no signiﬁcant delay at 100 lM. Based on
these results, NO triggered a signiﬁcant delay in the opening of
the cardiac mitochondrial PT pore only at the low concentrations
of NO donors. These effects of NO paralleled those on VDAC.
4. Discussion
The results from this study provided functional evidence of the
novel ability of exogenous NO to inhibit the cardiac VDAC in a con-
centration-dependent biphasic manner. This effect was direct and
independent of guanylate cyclase since no cytosolic factors were
present. The range of NO levels where the inhibition of VDAC
was observed was within the physiological range associated with
Fig. 2. Effect of exogenous NO on VDAC. Panel A: Sample VDAC current traces are shown in control and in the presence of 25 lM PAPA NONOate (PPN). Recordings were
obtained at a membrane potential of 10 mV. The dashed lines indicate zero current levels. The amplitude histogram is cumulative from n = 10 separate recordings. Panel B:
Sample VDAC recording is shown in the presence of 50 lM PPN. The amplitude histogram is cumulative from n = 5 separate recordings. Panel C: VDAC current traces were
recorded in control and in the presence of 25 lM PPN in response to a voltage ramp protocol from 80 to +80 mV. The holding potential was set at 0 mV. Recordings from
n = 3/group are superimposed. In the presence of PPN, the dominant VDAC state was the low conductance ‘‘closed’’ state.
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limited range of NO levels, 120–900 nM, suggesting a rather steep
sensitivity of VDAC to NO. A similar concentration-dependent bi-
phasic effect of NO was also observed in delaying mitochondrial
PT pore opening. The NO-induced delay in PT pore opening paral-
leled the effect of NO in triggering the transition of VDAC to the‘‘closed’’ state, implicative of a synergistic effect. Furthermore, at
higher concentrations, the effects of NO on both VDAC and the
PT pore were abolished.
Recent studies have brought into question the role of the VDAC
as being part of the PT pore [5]. Genetic knock-out studies showed
that PT pore opening can occur in the absence of VDAC [13].
Fig. 3. Stability of VDAC activity in planar bilayers. VDAC recordings were monitored over a 30-min period to rule out time-dependent changes. The sequential amplitude
histograms are cumulative from n = 5 separate recordings. At the onset of each time point depicted, VDAC activity was acquired during a 2-min recording duration.
Fig. 4. Concentration-dependent effects of NO on VDAC. Panel A: The concentration–response curve for various concentrations of PPN on the VDAC mean current amplitude
is shown (n = 5–10/group). Panel B: The steady-state levels of NO generated by the various concentrations of PPN are shown. NO levels were measured using the APOLLO
4000 free radical analyzer (World Precision Instruments; n = 3/group). Panel C: Summary of the effects of 25 lM PPN in the absence and presence of PTIO is shown. Vehicle
was composed of the base solution of 10 mM NaOH diluted 1:200 to mimic the solution the PPN was prepared in. ⁄ Denotes signiﬁcantly different from the vehicle and
PTIO + PPN groups.
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cell survival as it is the main gateway for the exchange of ATP,
ADP and metabolites across the outer mitochondrial membrane
[8]. Previous studies have demonstrated that closure of VDAC by
hexokinase prevented opening of the PT pore, and hence apopto-
sis [14]. However, at the time of that study, VDAC was considered
to be part of the PT pore complex. Based on the current view that
VDAC is not part of the PT pore complex, our study raises an
intriguing possibility that low levels of NO afford cardioprotection
by its dual effects on VDAC and the PT pore. While opening of the
PT pore, the end-stage mitochondrial event leading to cell death,is delayed by NO, it is conceivable, although speculative at this
time, the effect of NO on VDAC may play a role in preserving
mitochondrial function, and, consequently, contributing as an up-
stream modulator in delaying the PT pore’s opening. Furthermore,
our observation that high concentrations of NO diminished both
the inhibitory effects on VDAC activity and delay in the PT pore
opening support the duality of NO on cardiac function whereby
low concentrations are cardioprotective, while high concentra-
tions are cardiotoxic. Thus, our results show that the tandem ef-
fects of NO on both VDAC and the PT pore can potentially
function synergistically.
Fig. 5. Effect of exogenous NO on the cardiac PT pore. Panel A: schematic of the experimental protocol used for measuring PT pore opening. TMRE denotes the loading time of
the ﬂuorescent dye and Tyrode denotes the incubation of the cardiomyocytes in this solution. The arrow indicates the time at which the PT pore opening measurements were
initiated. Panel B: changes in TMRE ﬂuorescence as a function of time in the presence of different concentrations of SNAP are shown. Opening of the PT pore was correlated
with the abrupt decrease in the ﬂuorescent signal. Panel C: summary of the effects of SNAP on time to PT pore opening is shown. Panel D: summary of PT pore opening times
recorded in cardiomyocytes in control and following pretreatment with 25 and 100 lM PPN. ⁄ Denotes signiﬁcantly different from control (n = 7–11/group in Panel C and 8/
group in Panel D).
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states in the presence of PPN observed in the present study is yet to
be determined. In fact, whether the ‘‘open’’ high conductance or
the ‘‘closed’’ low conductance states of VDAC contributes to cardio-
protection is currently unresolved. A complex biophysical property
of VDAC is its ability to conduct negatively charged nucleotides
and metabolites at the high conductance ‘‘open’’ state and cations
such as calcium at the low conductance ‘‘closed’’ state [15]. Phos-
phorylation of VDAC induces the low conductance ‘‘closed’’ state,
and discrepancies abound as to whether phosphorylation or
dephosphorylation of VDAC is cardioprotective. For example, VDAC
has been identiﬁed as one of the phosphorylation targets of PKC-e
translocation to the OMM triggered by preconditioning [16]. Yet, a
signiﬁcant reduction in the ischemia-induced phosphorylation of
VDAC was found to underlie the cardioprotective mechanism of
an inhibitor of p38 mitogen-activated protein kinase [17]. Conse-
quently, these studies suggest that VDAC is highly modulated
and that this modulation is a crucial component of cardioprotec-
tion. The biphasic effect of NO on VDAC likely contributes to this
modulation.
VDAC has been reported to be a binding partner of eNOS, and
this interaction was shown to increase eNOS activity [18]. In our
study, because puriﬁed VDAC was incorporated into an artiﬁcial bi-
layer, the confounding impact of eNOS was absent. On the other
hand, the close interaction of eNOS with VDAC coupled with the di-rect effect of NO on VDAC suggests a highly regulated and efﬁcient
modulation of the channel protein. However, the mechanism of the
biphasic NO effect on VDAC has yet to be determined. Based on the
sequence and structure of VDAC, there are two cysteine residues
that may potentially be sites for S-nitrosylation [19]. Modiﬁcation
by S-nitrosylation is associated with protein regulation and has
been shown to be involved in apoptosis [20,21]. The correlation be-
tween S-nitrosylation and the biphasic inhibition of VDAC requires
further studies. Given the complex biophysical characteristic of
VDAC, other modulators of the channel may also impact its regula-
tion by NO.
We have previously reported on the activating effect of NO on
the mitochondrial ATP-sensitive potassium channel [7]. Thus, NO
may be an important modulator of mitochondrial ion channels.
However, what the cumulative effects of NO on these ion channels
in modulating mitochondrial function are, and the exact roles of
these channels have in contributing to cardioprotection are yet to
be determined.5. Conclusion
In summary, our results showed that NO directly inhibited the
cardiac mitochondrial VDAC in a biphasic manner. This inhibition
paralleled the delay in the opening of the cardiac PT pore by NO.
334 Q. Cheng et al. / FEBS Letters 585 (2011) 328–334This tandem, synergistic effect on both the VDAC and PT pore may
potentially contribute to the cardioprotective effects of low levels
of NO.
Acknowledgements
The authors thank Drs. Martin Bienengraeber and Johan Hau-
mann at the Medical College of Wisconsin for helpful scientiﬁc dis-
cussions. Supported by P01 GM066730 to Z.J.B.
References
[1] Phillips, L., Toledo, A.H., Lopez-Neblina, F., Anaya-Prado, R. and Toledo-Pereyra,
L.H. (2009) Nitric oxide mechanism of protection in ischemia and reperfusion
injury. J. Invest. Surg. 22, 46–55.
[2] Bell, R.M., Maddock, H.L. and Yellon, D.M. (2003) The cardioprotective and
mitochondrial depolarising properties of exogenous nitric oxide in mouse
heart. Cardiovasc. Res. 57, 405–415.
[3] Brookes, P.S., Salinas, E.P., Darley-Usmar, K., Eiserich, J.P., Freeman, B.A.,
Darley-Usmar, V.M. and Anderson, P.G. (2000) Concentration-dependent
effects of nitric oxide on mitochondrial permeability transition and
cytochrome c release. J. Biol. Chem. 275, 20474–20479.
[4] Kim, J.S., Ohshima, S., Pediaditakis, P. and Lemasters, J.J. (2004) Nitric oxide: a
signaling molecule against mitochondrial permeability transition- and pH-
dependent cell death after reperfusion. Free Radic. Biol. Med. 37, 1943–1950.
[5] Halestrap, A.P. (2009) What is the mitochondrial permeability transition pore?
J. Mol. Cell. Cardiol. 46, 821–831.
[6] Burwell, L.S. and Brookes, P.S. (2008) Mitochondria as a target for the
cardioprotective effects of nitric oxide in ischemia-reperfusion injury.
Antioxid. Redox Signal. 10, 579–599.
[7] Ljubkovic, M., Shi, Y., Cheng, Q., Bosnjak, Z. and Jiang, M.T. (2007) Cardiac
mitochondrial ATP-sensitive potassium channel is activated by nitric oxide
in vitro. FEBS Lett. 581, 4255–4259.
[8] Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan, N. and
Arbel, N. (2010) VDAC, a multi-functional mitochondrial protein regulating
cell life and death. Mol. Aspects Med. 31, 227–285.[9] Gincel, D., Vardi, N. and Shoshan-Barmatz, V. (2002) Retinal voltage-
dependent anion channel: characterization and cellular localization. Invest.
Ophthalmol. Vis. Sci. 43, 2097–2104.
[10] Pravdic, D., Sedlic, F., Mio, Y., Vladic, N., Bienengraeber, M. and Bosnjak, Z.J.
(2009) Anesthetic-induced preconditioning delays opening of mitochondrial
permeability transition pore via protein kinase C-epsilon-mediated pathway.
Anesthesiology 111, 267–274.
[11] Zorov, D.B., Filburn, C.R., Klotz, L.O., Zweier, J.L. and Sollott, S.J. (2000) Reactive
oxygen species (ROS)-induced ROS release: a new phenomenon accompanying
induction of the mitochondrial permeability transition in cardiac myocytes. J.
Exp. Med. 192, 1001–1014.
[12] Tampo, A., Hogan, C.S., Sedlic, F., Bosnjak, Z.J. and Kwok, W.M. (2009)
Accelerated inactivation of cardiac L-type calcium channels triggered by
anaesthetic-induced preconditioning. Br. J. Pharmacol. 156, 432–443.
[13] Baines, C.P., Kaiser, R.A., Sheiko, T., Craigen, W.J. and Molkentin, J.D. (2007)
Voltage-dependent anion channels are dispensable for mitochondrial-
dependent cell death. Nat. Cell Biol. 9, 550–555.
[14] Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S. and Shoshan-Barmatz, V.
(2004) In self-defence: hexokinase promotes voltage-dependent anion
channel closure and prevents mitochondria-mediated apoptotic cell death.
Biochem. J. 377, 347–355.
[15] Colombini, M. (1983) Puriﬁcation of VDAC (voltage-dependent anion-selective
channel) from rat liver mitochondria. J. Membr. Biol. 74, 115–121.
[16] Baines, C.P. et al. (2003) Protein kinase Cepsilon interacts with and inhibits the
permeability transition pore in cardiac mitochondria. Circ. Res. 92, 873–880.
[17] Schwertz, H. et al. (2007) Myocardial ischemia/reperfusion causes VDAC
phosphorylation which is reduced by cardioprotection with a p38 MAP kinase
inhibitor. Proteomics 7, 4579–4588.
[18] Sun, J. and Liao, J.K. (2002) Functional interaction of endothelial nitric oxide
synthase with a voltage-dependent anion channel. Proc. Natl. Acad. Sci. USA
99, 13108–13113.
[19] Ujwal, R., Cascio, D., Colletier, J.P., Faham, S., Zhang, J., Toro, L., Ping, P. and
Abramson, J. (2008) The crystal structure of mouse VDAC1 at 2.3 Å resolution
reveals mechanistic insights into metabolite gating. Proc. Natl. Acad. Sci. USA
105, 17742–17747.
[20] Stamler, J.S., Toone, E.J., Lipton, S.A. and Sucher, N.J. (1997) (S)NO signals:
translocation, regulation, and a consensus motif. Neuron 18, 691–696.
[21] Yabuki, M., Tsutsui, K., Horton, A.A., Yoshioka, T. and Utsumi, K. (2000) Caspase
activation and cytochrome c release during HL-60 cell apoptosis induced by a
nitric oxide donor. Free Radic. Res. 32, 507–514.
